-
Something wrong with this record ?
HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients
P Cejkova, P Novota, M Cerna, K Kolostova, D Novakova, P Kucera, J Novak, M Andel, P Weber, E Zdarsky
Language English Country Great Britain
Document type Multicenter Study
NLK
Medline Complete (EBSCOhost)
from 2005-02-01 to 1 year ago
Wiley Online Library (archiv)
from 1997-01-01 to 2012-12-31
- MeSH
- Alleles MeSH
- Diabetes Mellitus, Type 1 genetics immunology MeSH
- Adult MeSH
- Gene Frequency genetics immunology MeSH
- Genetic Predisposition to Disease MeSH
- HLA-DQ Antigens genetics immunology MeSH
- HLA-DR Antigens genetics immunology MeSH
- Insulin genetics immunology MeSH
- Middle Aged MeSH
- Humans MeSH
- Minisatellite Repeats genetics MeSH
- Age of Onset MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Multicenter Study MeSH
- Geographicals
- Czech Republic MeSH
Both the human leucocyte antigen (HLA) DRB1 and the HLA DQB1 gene loci play a role in the development and progression of autoimmune diabetes mellitus (T1DM). Similarly, the insulin promoter variable number tandem repeats (INS-VNTR) polymorphism is also involved in the pathogenesis of diabetes mellitus (DM). We studied the association between each of these polymorphisms and DM diagnosed in patients older than age 35 years. Furthermore, we analysed possible interactions between HLA DRB1/DQB1 and INS-VNTR polymorphisms. Based on C-peptide and GADA levels we were able to distinguish three types of diabetes: T1DM, latent autoimmune diabetes in adults (LADA) and T2DM. INS-VNTR was genotyped indirectly by typing INS-23HphI A/T polymorphism. The genotype and allele frequencies of INS-23HphI did not differ between each of the diabetic groups and group of healthy subjects. We did, however, observe an association between the INS-23HphI alleles, genotypes and C-peptide secretion in all diabetic patients: A allele frequency was 86.2% in the C-peptide-negative group vs. 65.4% in the C-peptide-positive group (P(corr.) < 0.005); AA genotype was found to be 72.4% in the C-peptide-negative group vs. 42.6% in the C-peptide-positive groups (P(corr.) < 0.01). The HLA genotyping revealed a significantly higher frequency of HLA DRB1*03 allele in both T1DM and LADA groups when compared to healthy subjects: T1DM (25.7%) vs. control group (10.15%), odds ratio (OR) = 3.06, P < 0.05; LADA (27.6%) vs. control (10.15%), OR = 3.37, P < 0.01. The simultaneous presence of both HLA DRB1*04 and INS-23HphI AA genotype was detected in 37.5% of the T1DM group compared to only 9.2% of the healthy individuals group (OR = 5.9, P(corr.) < 0.007). We summarize that in the Central Bohemian population of the Czech Republic, the INS-23HphI A allele appears to be associated with a decrease in pancreatic beta cell secretory activity. HLA genotyping points to at least a partial difference in mechanism, which leads to T1DM and LADA development as well as a more diverse genetic predisposition in juvenile- and adult-onset diabetes. The simultaneous effect of HLA and INS-VNTR alleles/genotypes predispose individuals to an increased risk of diabetes development.
- 000
- 04558naa 2200613 a 4500
- 001
- bmc11003051
- 003
- CZ-PrNML
- 005
- 20121123105603.0
- 008
- 110225s2008 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Daňková, Pavlína $7 xx0146621
- 245 10
- $a HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients / $c P Cejkova, P Novota, M Cerna, K Kolostova, D Novakova, P Kucera, J Novak, M Andel, P Weber, E Zdarsky
- 314 __
- $a Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Pavlina.Cejkova@lf3.cuni.cz
- 520 9_
- $a Both the human leucocyte antigen (HLA) DRB1 and the HLA DQB1 gene loci play a role in the development and progression of autoimmune diabetes mellitus (T1DM). Similarly, the insulin promoter variable number tandem repeats (INS-VNTR) polymorphism is also involved in the pathogenesis of diabetes mellitus (DM). We studied the association between each of these polymorphisms and DM diagnosed in patients older than age 35 years. Furthermore, we analysed possible interactions between HLA DRB1/DQB1 and INS-VNTR polymorphisms. Based on C-peptide and GADA levels we were able to distinguish three types of diabetes: T1DM, latent autoimmune diabetes in adults (LADA) and T2DM. INS-VNTR was genotyped indirectly by typing INS-23HphI A/T polymorphism. The genotype and allele frequencies of INS-23HphI did not differ between each of the diabetic groups and group of healthy subjects. We did, however, observe an association between the INS-23HphI alleles, genotypes and C-peptide secretion in all diabetic patients: A allele frequency was 86.2% in the C-peptide-negative group vs. 65.4% in the C-peptide-positive group (P(corr.) < 0.005); AA genotype was found to be 72.4% in the C-peptide-negative group vs. 42.6% in the C-peptide-positive groups (P(corr.) < 0.01). The HLA genotyping revealed a significantly higher frequency of HLA DRB1*03 allele in both T1DM and LADA groups when compared to healthy subjects: T1DM (25.7%) vs. control group (10.15%), odds ratio (OR) = 3.06, P < 0.05; LADA (27.6%) vs. control (10.15%), OR = 3.37, P < 0.01. The simultaneous presence of both HLA DRB1*04 and INS-23HphI AA genotype was detected in 37.5% of the T1DM group compared to only 9.2% of the healthy individuals group (OR = 5.9, P(corr.) < 0.007). We summarize that in the Central Bohemian population of the Czech Republic, the INS-23HphI A allele appears to be associated with a decrease in pancreatic beta cell secretory activity. HLA genotyping points to at least a partial difference in mechanism, which leads to T1DM and LADA development as well as a more diverse genetic predisposition in juvenile- and adult-onset diabetes. The simultaneous effect of HLA and INS-VNTR alleles/genotypes predispose individuals to an increased risk of diabetes development.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věk při počátku nemoci $7 D017668
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a diabetes mellitus 1. typu $x genetika $x imunologie $7 D003922
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a frekvence genu $x genetika $x imunologie $7 D005787
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a HLA-DQ antigeny $x genetika $x imunologie $7 D006683
- 650 _2
- $a HLA-DR antigeny $x genetika $x imunologie $7 D006684
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inzulin $x genetika $x imunologie $7 D007328
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a minisatelitní repetice $x genetika $7 D018598
- 650 _2
- $a Minisatellite Repeats $x im [Immunology]
- 650 _2
- $a Polymorphism, Genetic
- 650 _2
- $a Promoter Regions, Genetic $x ge [Genetics]
- 650 _2
- $a Promoter Regions, Genetic $x im [Immunology]
- 650 _2
- $a Risk Factors
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Novota, Peter $7 xx0061182
- 700 1_
- $a Černá, Marie, $d 1964- $7 mzk2004258459
- 700 1_
- $a Kološtová, Katarína. $7 xx0207726
- 700 1_
- $a Nováková, Dana, $d 1950- $7 xx0079110
- 700 1_
- $a Kučera, Petr, $d 1957- $7 xx0070805
- 700 1_
- $a Novák, Jan, $d 1974- $7 xx0074930
- 700 1_
- $a Anděl, Michal, $d 1946- $7 jn19981228006
- 700 1_
- $a Weber, Pavel $7 xx0102175
- 700 1_
- $a Žďárský, Emanuel, $d 1957- $7 jn20000402981
- 773 0_
- $t International Journal of Immunogenetics $w MED00008484 $g Roč. 35, č. 2 (2008), s. 133-140
- 910 __
- $a ABA008 $b x $y 1
- 990 __
- $a 20110413114125 $b ABA008
- 991 __
- $a 20121123105626 $b ABA008
- 999 __
- $a ok $b bmc $g 830445 $s 695043
- BAS __
- $a 3
- BMC __
- $a 2008 $b 35 $c 2 $d 133-140 $m International journal of immunogenetics $n Int J Immunogen $x MED00008484
- LZP __
- $a 2011-2B/dkme